Vitalhub Corp. (TSE:VHI - Get Free Report) has received an average recommendation of "Buy" from the seven research firms that are covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is C$14.08.
VHI has been the topic of several research analyst reports. Raymond James Financial lifted their target price on Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a research note on Tuesday, August 12th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. National Bankshares set a C$16.00 target price on Vitalhub and gave the company an "outperform" rating in a research note on Thursday, August 21st. TD Securities lifted their target price on Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a research note on Monday, August 11th. Finally, Scotiabank lifted their target price on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research note on Friday, June 20th.
Check Out Our Latest Report on Vitalhub
Vitalhub Trading Down 1.2%
TSE:VHI traded down C$0.15 on Friday, hitting C$12.60. 79,919 shares of the company's stock traded hands, compared to its average volume of 151,801. Vitalhub has a 1 year low of C$7.62 and a 1 year high of C$14.64. The firm has a 50-day moving average price of C$12.52 and a 200-day moving average price of C$11.03. The company has a market cap of C$791.66 million, a PE ratio of 157.50, a price-to-earnings-growth ratio of 1.18 and a beta of 1.09.
About Vitalhub
(
Get Free Report)
Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.
Further Reading
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
